Drugs / vCP1433
last change Aug 1999 re-read 2 minutes ago

vCP1433

also known as ALVAC(1)120(B,MN)GNP
Developed for
HIV infectious disease
Investigated by
National Institute of Allergy and Infectious Diseases (NIAID)

Trials 1 · a red edge is where a trial was stopped

19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00000904 ? → Aug 1999 HIV infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as vCP1433 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000904
Known as ALVAC(1)120(B,MN)GNP ALVAC(1)120(B,MN)GNP (vCP1433)” NCT00000904